Chinese University of Hong Kong: Non-alcoholic Fatty Liver Disease trials
The registry lists 10 Non-alcoholic Fatty Liver Disease studies with Chinese University of Hong Kong as lead sponsor. 3 are open to participants now and 1 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With ObesityRecruitingNCT07662356
- Duodenal pulsENDO as an Early Treatment for Type 2 DMRecruitingNCT07376486Not applicable
- Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style InterventionRecruitingNCT03875625Not applicable
- Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder MessagesCompletedNCT04241575Not applicableResults posted
- Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis AssessmentActive, not recruitingNCT05384652
- Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based StudyTerminatedNCT04440540Not applicable
- Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT02728765Not applicable
- Trial of Hepaguard® in Adults With Nonalcoholic SteatohepatitisCompletedNCT01210989Not applicable
- Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and PrebioticsCompletedNCT00870012Not applicable
- Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver DiseaseCompletedNCT00868933Not applicable